Contrast Anthropomorphic Breast Phantoms
Closed Special Notice Posted
- Solicitation number
- 75F40123Q00399
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food & Drug Administration (FDA) plans to award a Sole Source contract to Phantomx GMBH for the provision of breast phantoms. The contract includes a base period and four one-year option periods. The phantoms will be used for analytical laboratory instrument manufacturing, with one phantom emulating x-ray attenuation of adipose tissue and the other four matching a virtual breast phantom supplied by the FDA.
List of Products and Services:
- Provision of breast phantoms
- One phantom with a uniform background breast shape emulating x-ray attenuation of adipose tissue
- Four phantoms with anthropomorphic breast background structure matching a virtual breast phantom supplied by the FDA.
Notice text
The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source award to Phantomx GMBH. The Government intends to issue a sole source award in accordance with FAR 6.302-1, only one responsible source and no other will satisfy the agency requirements for the above stated service.
The scope of the work is to provide breast phantoms. One phantom shall have a uniform background breast shape emulating x-ray attenuation of adipose tissue with 10, 10 mm long cylinders of radius 5 mm , two masses with each iodine concentration of 0.25 mg/ml, 0.5 mg/ml, 1.0 mg/ml, and 2.0 mg/ml
The other four phantoms shall have anthropomorphic breast background structure matching a virtual breast phantom supplied by the FDA.
The NAICS Code is: 334516 Analytical Laboratory Instrument Manufacturing.
The Vendor to be awarded:
Phantomx GMBH
Schwedenster.14
Berlin
Germany
This will be a firm fixed price award for a Base Period and four (4) one (1) year Option Periods.
This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement to Iris Johnson, Iris.Johnson1@fda.hhs.gov in writing and must be within five (5) days after date of publication of this notice which may be considered by the agency. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
No phone calls will be accepted.
Attachments
| File | Type | Posted |
|---|---|---|
| NOI_CDRH-2023-117782.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity